X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: A meta-analysis

World Journal of Gastroenterology

Volumn 18, Issue 31, 2012, Pages 4207-4214

  Xie, Tian ^a   Wang, Zhen Guang ^b   Zhang, Jing Lei ^b   Liu, Hui ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Meta analysis; Polymorphism; X ray repair cross complementing group 1

Indexed keywords

ARGININE; GLUTAMINE; HISTIDINE; TRYPTOPHAN; XRCC1 PROTEIN;

ARTICLE; CANCER RISK; DNA POLYMORPHISM; EMBASE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; MEDLINE; META ANALYSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

EID: 84867718069     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i31.4207     Document Type: Article

References (35)

1. Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 2009; 44 Suppl 19: 96-101
2. Sato K, Mori M. Evolving molecular mechanism-based strategies for control of hepatocellular carcinoma. Curr Med Chem 2011; 18: 4375-4388
3. Lahtz C, Pfeifer GP. Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol 2011; 3: 51-58
4. Jiang J, Zhang X, Yang H, Wang W. Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. Methods Mol Biol 2009; 471: 305-333
5. Thompson LH, Bachinski LL, Stallings RL, Dolf G, Weber CA, Westerveld A, Siciliano MJ. Complementation of repair gene mutations on the hemizygous chromosome 9 in CHO: a third repair gene on human chromosome 19. Genomics 1989; 5: 670-679
6. Dianov GL, Sleeth KM, Dianova II, Allinson SL. Repair of abasic sites in DNA. Mutat Res 2003; 531: 157-163
7. Thompson LH, West MG. XRCC1 keeps DNA from getting stranded. Mutat Res 2000; 459: 1-18
8. Whitehouse CJ, Taylor RM, Thistlethwaite A, Zhang H, Karimi-Busheri F, Lasko DD, Weinfeld M, Caldecott KW. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 2001; 104: 107-117
9. Chen B, Zhou Y, Yang P, Wu XT. Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol Biol Rep 2012; 39: 1305-1313
10. Huang GL, Guo HQ, Yu CY, Liu XY, Li BB, Wu JJ, He ZW. XRCC1 polymorphisms and risk of nasopharyngeal carcinoma: a meta-analysis. Asian Pac J Cancer Prev 2011; 12: 2329-2333
11. Huang J, Zhang J, Zhao Y, Liao B, Liu J, Li L, Liao M, Wang L. The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Mol Biol Rep 2011; 38: 4565-4573
12. Huang Y, Li L, Yu L. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a metaanalysis. Mutagenesis 2009; 24: 331-339
13. Liu F, Li B, Wei Y, Yan L, Wen T, Zhao J, Xu M. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liver Int 2011; 31: 802-809
14. Liu L, Yuan P, Liu L, Wu C, Zhang X, Guo H, Zhong R, Xu Y, Wu J, Duan S, Rui R, Wu T, Nie S, Miao X, Lin D. A functional-77T& gt; C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res Treat 2011; 125: 479-487
15. Zhang H, Li W, Franklin MJ, Dudek AZ. Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a metaanalysis. Anticancer Res 2011; 31: 3945-3952
16. Zheng H, Wang Z, Shi X, Wang Z. XRCC1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 2009; 65: 268-273
17. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med 2005; 24: 1291-1306
18. Zintzaras E, Ioannidis JP. Heterogeneity testing in metaanalysis of genome searches. Genet Epidemiol 2005; 28: 123-137
19. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
20. Borentain P, Gérolami V, Ananian P, Garcia S, Noundou A, Botta-Fridlund D, Le Treut YP, Bergé-Lefranc JL, Gérolami R. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. Eur J Cancer 2007; 43: 2479-2486
21. Han YN, Yang JL, Zeng SG, Wu YQ. Study on the association of human XRCC1-399 single nucleotide polymorphism and primary hepatocytic carcinoma. Ganzang 2004; 9: 235-237
22. Kiran M, Saxena R, Chawla YK, Kaur J. Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem 2009; 327: 7-13
23. Kirk GD, Turner PC, Gong Y, Lesi OA, Mendy M, Goedert JJ, Hall AJ, Whittle H, Hainaut P, Montesano R, Wild CP. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev 2005; 14: 373-379
24. Long XD, Ma Y, Wei YP, Deng ZL. Polymorphism of DNA repair gene XRCC1 and risk of hepatocellular carcinoma. Guangxi Yike Daxue Xuebao 2004; 21: 313-315
25. Ren Y, Wang D, Li Z, Xin Y, Yin J, Zhang B, Ding H, Li N. Study on the Relationship between Gene XRCC1 Codon Single Nucleotide Polymorphisms and Primary Hepatic Carcinoma in Han Nationality. Linchuang Ganzangbing Zazhi 2008; 24: 361-364
26. Tang Y, Li X, Liu T, Yang J, Luo J, Liang Z. Genetic polymorphisms of DNA repair genes in patients with hepatocellular carcinoma. Shandong Yiyao 2011; 51: 19-20
27. Wu H, Yang Z, Xie Y, Kuang Z, Luo X, Liang A, Luo J. Correlation between DNA repair gene XRCC1 Arg280His polymorphism and susceptibility to hepatocellular carcinoma in Fusui county of Guangxi. Zhongguo Xiandai Yixue Zazhi 2009; 19: 2737-2740, 2743
28. Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Chen PJ, Lee SD, Chen CJ. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst 2003; 95: 1485-1488
29. Zeng X, Yu H, Qiu X, Ji L, Li L. A case-control study of polymorphism of XRCC1 gene and the risk of hepatocellular carcinoma. Zhongguo Jibing Kongzhi Zazhi 2010; 14: 760-763
30. Bo W, Zhang G, Li D, Wang X, Liang T. Polymorphisms of DNA repair gene XRCC1 and susceptibility to hepatic cancer. Xiandai Zhongliu Yixue 2011; 19: 1724-1726
31. Poehlmann A, Roessner A. Importance of DNA damage checkpoints in the pathogenesis of human cancers. Pathol Res Pract 2010; 206: 591-601
32. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 1998; 58: 604-608
33. Gsur A, Bernhart K, Baierl A, Feik E, Führlinger G, Hofer P, Leeb G, Mach K, Micksche M. No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk. Cancer Epidemiol 2011; 35: e38-e41
34. Wei B, Zhou Y, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, Hu Q, Wang Q, Wang Z, Yan Z. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a metaanalysis. Prostate Cancer Prostatic Dis 2011; 14: 225-231
35. Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G, Zhu Y, Miao X, Tan W, Wei Q, Lin D, He F. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 2004; 64: 4378-4384